News Sentiment

WHWK sentiment intelligence

Whitehawk Therapeutics, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 55 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.97 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-5.3% over one week, -4.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Sees Large Increase in Short Interest

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -5.3% Price reacting lower
Trend fit Trend active -4.6% over four weeks
Fair value 44.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 41
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 14
Stock Titan 12
Market source 8
PR Newswire 5
simplywall.st 3
MarketBeat 2
Finviz 2
StockStory 1

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 18
Analyst action 5
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-55 of 55
Market source Direct company coverage

Is Whitehawk Therapeutics (WHWK) One Of The Hot Biotech Stocks Under $5 To Buy?

Whitehawk Therapeutics (WHWK) is highlighted as a hot biotech stock under $5, with a year-to-date gain of 71.49%. The company has been active with pipeline developments, including presenting real-world data for its ADC HWK-206 at ASCO 2026 and expanding its pipeline through an op

Tone
Positive 77/100
Event
Market update
Published
10 Jun 2026 18:22
Source
Market source
Stock Titan Direct company coverage

[EFFECT] Whitehawk Therapeutics, Inc. SEC Filing

Whitehawk Therapeutics, Inc. (WHWK) has announced an SEC filing with a "Notice of Effectiveness" for its S-3 Shelf Registration, dated June 9, 2026, at 4:00 P.M. The filing impact and sentiment are noted as "Neutral." The company's stock data and recent news, including presentati

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 10:13
Source
Stock Titan